NEWS
2021810
PRHeartseed named “Ministry of Education, Culture, Sports, Science and Technology (MEXT) Award” at Academic Startups 2021
202172
OtherLAPiS Study, a Phase I/II Study of iPS Cell-derived Cardiomyocyte Spheroids (HS-001) in Patients With HF is posted on ClinicalTrials.gov
202161
PRHeartseed and Novo Nordisk enter into global collaboration and licence agreement for stem cell-based therapy for heart failure
2021421
MediaHeartseed was featured as a cover story in Startup City Magazine’s “Top 10 Startups in Japan”
2021323
PRHeartseed Initiates Ph1/2 Clinical Trial of iPSC-derived Cardiomyocyte Spheroids (LAPiS Study) in Japan